The value of positron emission tomography (PET) for therapeutic management in patients with cancer of unknown primary (CUP);Bedeutung der positronenemissionstomographie (PET) für die behandlung von patienten mit unbekanntem primärtumor (CUP)

Strahlentherapie und Onkologie

Volumn 177, Issue 10, 2001, Pages 525-529

  Rades, Dirk ^a   Kühnel, Grit ^b   Wildfang, Ingeborg ^a   Börner, Anne Rose ^a   Knapp, Wolfram ^a   Karstens, Johann Hinrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Cancer of unknown primary (CUP); Positron emission tomography (PET); Therapeutic strategies

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; METHOTREXATE; VINCRISTINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER LOCALIZATION; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DISSEMINATED CANCER; ENDOSCOPY; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PAROTID GLAND CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TONSIL CARCINOMA; URETHRA CARCINOMA; UTERINE TUBE CARCINOMA; VAGINA CARCINOMA;

EID: 17544396495     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002363     Document Type: Article

References (18)

1. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors
2. Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients
3. Applications of PET in lung cancer
4. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
5. FDG PET detection of unknown primary tumors
6. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation
7. Occult primary tumors of the head and neck: Tack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose
8. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
9. Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose
10. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models
11. CUP
12. FDG PET in head and neck cancer
13. Detection of unknown occult primary tumors using positron emission tomography
14. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)
15. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers
16. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck
17. Clinical value of positron emission tomography (PET) in oncologic questions: Results of an interdisciplinary consensus conference
18. Relevance of positron emission tomography (PET) in oncology